Luis Brieva (Luis Brieva Ruiz)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Lipopolysaccharide Induced

Immune Response

Top Venues

Journal of neurology

Pharmaceuticals (Basel, Switzerland)

Scientific reports

Neurodegenerative disease management

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Gil-Sánchez, Hugo Gonzalo, Marc Canudes, Lara Nogueras, Cristina González-Mingot, Petya Valcheva, Pascual Torres, Jose Carlos Serrano, Silvia Peralta, Maria José Solana, Luis Brieva
Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis? Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Anna Gil-Sánchez, Hugo Gonzalo, Marc Canudes, Lara Nogueras, Cristina González-Mingot, Petya Valcheva, Pascual Torres, Jose Carlos Serrano, Silvia Peralta, Maria José Solana, Luis Brieva
Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis? Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Cristina González-Mingot, Sonia Santos-Lasaosa, Laura Colàs Campàs, Laura Chilangua Canaval, Anna Gil-Sánchez, Luis Brieva, María Cristina Marzo Alonso, Silvia Peralta Moncusi, Joan Valls Marsal, Serafi Cambray, Francisco F Purroy
Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study. Scientific reports 13 (1) (2023)
Pascual Torres, Agustín Sancho-Saldaña, Anna Gil Sánchez, Silvia Peralta, Maria José Solana, Sofian Bakkioui, Cristina González-Mingot, Laura Quibus, Emilio Ruiz-Fernández, Eduardo San Pedro-Murillo, Luis Brieva
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies. Journal of neurology (2023)
Pascual Torres, Agustín Sancho-Saldaña, Anna Gil Sánchez, Silvia Peralta, Maria José Solana, Sofian Bakkioui, Cristina González-Mingot, Laura Quibus, Emilio Ruiz-Fernández, Eduardo San Pedro-Murillo, Luis Brieva
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies. Journal of neurology (2023)
José E Meca-Lallana, Juan Antonio García-Merino, Sergio Martínez-Yélamos, Ángela Vidal-Jordana, Lucienne Costa, Alfredo Rodríguez-Antigüedad, Àlex Rovira, Luis Brieva, Eduardo Agüera
Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies. Neurodegenerative disease management 11 (3) (2021)